Atlas Trials

Superselective Adrenal Arterial Embolization for Refractory Hypertension: A Proof-of-Concept Study

Clinical trial NCT06568640 · RECRUITING

Trial details

NCT number
NCT06568640
Sponsor
Second Affiliated Hospital of Nanchang University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Essential Hypertension
Start date
2024-08-01
Primary completion
2027-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.